Registered number
10765210
National Care Consortium Limited
Report and Financial Statements
31 October 2025
National Care Consortium Limited
Report and accounts
Contents
Page
Company information 1
Directors' report 2
Strategic report 3
Independent auditor's report 4
Income statement 7
Statement of financial position 8
Statement of changes in equity 9
Statement of cash flows 10
Notes to the financial statements 11
National Care Consortium Limited
Company Information
Directors
Mr M Younas
Mr R Younas
Mr S Younas
Mr T Younas
Mr A Younas
Accountants
Imperial Accounting
57 Radford Road
Nottingham
NG7 5DR
Auditors
Adam & Co Accountancy Ltd
1 Edmund Street
Bradford
West Yorkshire
BD5 0BH
Bankers
Barclays bank plc
City centre branch
Nottingham
Solicitors
Cleggs Solicitors
Apex Court, Ruddington Lane
Wilford
Nottingham
NG11 7DD
Registered office
Younas House
1 Pelham Court
Pelham Road
Nottingham
NG5 1AP
Registered number
10765210
National Care Consortium Limited Registered number: 10765210
Directors' Report
The directors present their report and financial statements for the year ended 31 October 2025.
Principal activities
The company's principal activity during the year continued to be provision of eldery care in care homes owned by the company.
Dividends
The directors recommend a final dividend of:
£ -
Directors
The following persons served as directors during the year:
Mr M Younas
Mr R Younas
Mr S Younas
Mr T Younas
Mr A Younas
Directors' responsibilities
The directors are responsible for preparing the report and financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 102 and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Disclosure of information to auditors
Each person who was a director at the time this report was approved confirms that:
so far as he is aware, there is no relevant audit information of which the company's auditor is unaware; and
he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditor is aware of that information.
This report was approved by the board on 15 May 2026 and signed on its behalf.
Mr T Younas
Director
National Care Consortium Limited
Strategic Report
Business review
Turnover for the 12 month period to 31 October 2025 reduced by 0.5% compared to the previous years.
This was due to a few residents leaving. However, the company continues to maintain its market
share.
Gross margins remained same as previous periods in order to maintain market share.
However the net margins suffered due to rising costs such as salaries, cleaning and increased bank
interest payable on new and old loans.
As a result the bottom line (net profit) suffered and was down compared to 2024 period.
Principal risks and uncertainties
The principal risks facing the company are rising costs, competition and recession due to
inflation, changes in law and regulations.
Financial key performance indicators (KPI)
The basic KPIs on which the company basis its financial evaluations are gross profit, net profit
and employee costs.
Use of key performance indicators
The company directors and managers attend monthly meetings to review the performance
of the company by using the KPIs discussed above
The company manages a robust cashflow to enable future growth and investment in technology.
The directors are to monitor costs and turnover to ensure the company can grow organically.
This report was approved by the board on 15 May 2026 and signed on its behalf.
Mr T Younas
Director
National Care Consortium Limited
Independent auditor's report
to the members of National Care Consortium Limited
Opinion
We have audited the financial statements of National Care Consortium Limited (the 'company') for the year ended 31 October 2025 which comprise the Income Statement, the Statement of Financial Position, the Statement of Changes in Equity, the Statement of Cash Flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 October 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice;
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
the information given in the strategic report and the directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors’ report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors’ report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors’ remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors’ responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
See next page for continuation of audit report.
Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
* Review of systems and procedures in place * Sampling records and *Analytical review. We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures response to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. In identifying and assessing the risks or material misstatements in respect of irregularities, including fraud and non-compliance with laws and regulations we considered the following; • The nature of the company, the environment in which it operates and the control procedures implemented by management/directors; and • Our enquiries of management about their identification and assessment of the risks of irregularities. Based on our understanding of the company and the sector we identified that the principal risks of non compliance with laws and regulations related to, but were not limited to; • Regulations and legislation pertinent to the company’s operations; We considered the extent to which non-compliance might have a material impact on the financial statements. We also considered those laws and regulations which have a direct impact on the preparation of the financial statements, such as the Companies Act 2006 and Taxation Act. We evaluated management and directors’ incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of management override of controls), and determined that the principal risks were related to; • Posting inappropriate journal entries.
Audit response to the risks identified; Our procedures to respond to the risks identified included the following; • Gaining an understanding of the legal and regulatory framework applicable to the company and the sector in which it operates; • Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements; • Enquiring of management concerning actual and potential litigation and claims; • Reading minutes of meetings of those charged with governance; • In addressing the risk of fraud as a result of management override of controls, testing the appropriateness of journal entries and other adjustments; evaluating rationale of any significant transactions that are unusual or outside the normal course of business. We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more
that compliance with a law or regulation is removed from the events and transactions reflected in the financial
statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater
regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery,
collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is available on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Shahbaz Munir (FCCA)
(Senior Statutory Auditor) 1 Edmund Street
for and on behalf of Bradford
Adam & Co Accountancy Ltd West Yorkshire
Statutory Auditor BD5 0BH
15 May 2026
National Care Consortium Limited
Income Statement
for the year ended 31 October 2025
Notes 2025 2024
£ £
Turnover 2 10,647,074 10,691,515
Cost of sales (320,362) (322,601)
Gross profit 10,326,712 10,368,914
Administrative expenses (9,452,883) (9,348,588)
Operating profit 3 873,829 1,020,326
Interest receivable - 222
Interest payable 5 (247,827) (317,354)
Profit on ordinary activities before taxation 626,002 703,194
Tax on profit on ordinary activities 6 (123,744) (184,301)
Profit for the financial year 502,258 518,893
National Care Consortium Limited
Statement of Financial Position
as at 31 October 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 7 7,289,725 7,200,441
Current assets
Stocks 8 16,786 14,872
Debtors 9 4,606,276 4,820,625
Cash at bank and in hand 772,256 616,573
5,395,318 5,452,070
Creditors: amounts falling due within one year 10 (460,363) (604,650)
Net current assets 4,934,955 4,847,420
Total assets less current liabilities 12,224,680 12,047,861
Creditors: amounts falling due after more than one year 11 (3,744,386) (4,069,825)
Net assets 8,480,294 7,978,036
Capital and reserves
Called up share capital 14 1,000 1,000
Other reserves 15 2,955,000 2,955,000
Profit and loss account 16 5,524,294 5,022,036
Total equity 8,480,294 7,978,036
- -
Mr T Younas
Director
Approved by the board on 15 May 2026
National Care Consortium Limited
Statement of Changes in Equity
for the year ended 31 October 2025
Share Share Other Profit Total
capital premium reserves and loss
account
£ £ £ £ £
At 1 November 2023 1,000 - - 4,503,143 4,504,143
Profit for the financial year 518,893 518,893
Gain on revaluation of land and buildings 2,955,000 2,955,000
Other comprehensive income for the financial year - - - - -
Total comprehensive income for the financial year 1,000 - 2,955,000 5,022,036 7,978,036
At 31 October 2024 1,000 - 2,955,000 5,022,036 7,978,036
At 1 November 2024 1,000 - 2,955,000 5,022,036 7,978,036
Profit for the financial year 502,258 502,258
Gain on revaluation of land and buildings - -
Other comprehensive income for the financial year - - - - -
Total comprehensive income for the financial year 1,000 - 2,955,000 5,524,294 8,480,294
At 31 October 2025 1,000 - 2,955,000 5,524,294 8,480,294
National Care Consortium Limited
Statement of Cash Flows
for the year ended 31 October 2025
Notes 2025 2024
£ £
Operating activities
Profit for the financial year after tax 502,258 518,893
Adjustments for:
Interest receivable - (222)
Interest payable 247,827 317,354
Tax on profit on ordinary activities 123,744 184,301
Depreciation 102,147 82,549
Increase in stocks (1,914) (2,551)
Decrease/(increase) in debtors 214,349 (765,430)
(Decrease)/increase in creditors (83,730) 100,163
1,104,681 435,057
Interest received - 222
Interest paid (247,827) (317,354)
Corporation tax paid (184,301) (140,376)
Cash generated by/(used in) operating activities * 672,553 (22,451)
Investing activities
Payments to acquire tangible fixed assets (191,431) -
Proceeds from sale of tangible fixed assets - -
Cash used in investing activities ** (191,431) -
Financing activities
Equity dividends paid - -
Repayment of loans (296,459) 409,023
Capital element of finance lease payments (28,980) (28,980)
Cash (used in)/generated by financing activities *** (325,439) 380,043
Net cash generated
Cash generated by/(used in) operating activities * 672,553 (22,451)
Cash used in investing activities ** (191,431) -
Cash (used in)/generated by financing activities *** (325,439) 380,043
Net cash generated 155,683 357,592
Cash and cash equivalents at 1 November b/f 616,573 258,981
Cash and cash equivalents at 31 October c/f 772,256 616,573
Cash and cash equivalents comprise:
Cash at bank c/f 772,256 616,573
National Care Consortium Limited
Notes to the Accounts
for the year ended 31 October 2025
1 Summary of significant accounting policies
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings None
Leasehold land and buildings Over their life
Plant and machinery, fixture & fittings 18% reducing balance
Motor vehicles 18% reducing balance
Investment property
Investment property is initially recognised at cost and then subsequently measured at fair value. Changes in value are recognised in profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction.

At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Analysis of turnover 2025 2024
£ £
Sales of goods and services rendered 10,647,074 10,691,515
By geographical market:
UK 10,647,074 10,691,515
3 Operating profit 2025 2024
£ £
This is stated after charging:
Depreciation of owned fixed assets 102,147 82,549
Auditors' remuneration for audit services 9,600 7,000
Accountants' remuneration for other services 15,000 13,200
Carrying amount of stock sold 320,362 322,601
4 Staff costs 2025 2024
£ £
Wages and salaries 6,571,577 6,125,856
Social security costs 635,951 454,057
Other pension costs 107,392 95,333
7,314,920 6,675,246
Average number of employees during the year Number Number
Administration and management 24 22
Health care assistants 221 212
Cleaners and kitchen staff 65 62
Handyman 8 6
Nurses 15 10
333 312
5 Interest payable 2025 2024
£ £
Bank loans and overdrafts 247,827 317,354
6 Taxation 2025 2024
Analysis of charge in period £ £
Current tax:
UK corporation tax on profits of the period 123,744 184,301
Tax on profit on ordinary activities 123,744 184,301
Factors affecting tax charge for period
The differences between the tax assessed for the period and the standard rate of corporation tax are explained as follows:
2025 2024
£ £
Profit on ordinary activities before tax 626,002 703,194
Standard rate of corporation tax in the UK 20% 20%
£ £
Profit on ordinary activities multiplied by the standard rate of corporation tax 125,200 140,639
Effects of:
Expenses not deductible for tax purposes (1,456) 43,662
Current tax charge for period 123,744 184,301
Factors that may affect future tax charges
Changes in corporation tax rates and capital allowances rates may afftect future tax charges.
7 Tangible fixed assets
Land and buildings Plant and machinery, fixture & fittings Motor vehicles Total
£ £ £ £
Cost
At 1 November 2024 6,824,384 584,305 227,722 7,636,411
Additions - 191,431 - 191,431
At 31 October 2025 6,824,384 775,736 227,722 7,827,842
Depreciation
At 1 November 2024 - 315,700 120,270 435,970
Charge for the year - 82,806 19,341 102,147
At 31 October 2025 - 398,506 139,611 538,117
Carrying amount
At 31 October 2025 6,824,384 377,230 88,111 7,289,725
At 31 October 2024 6,824,384 268,605 107,452 7,200,441
2025 2024
£ £
Carrying amount of land and buildings on cost basis 3,869,384 3,869,384
2025 2024
£ £
Carrying value of plant and machinery included above held under finance leases and hire purchase contracts 136,370 165,688
8 Stocks 2025 2024
£ £
Raw materials and consumables 16,786 14,872
9 Debtors 2025 2024
£ £
Trade debtors 497,476 825,325
Amounts owed by group undertakings and undertakings in which the company has a participating interest 2,048,800 2,048,800
Other debtors 2,060,000 1,946,500
4,606,276 4,820,625
Amounts due after more than one year included in:
Amounts owed by group undertakings and undertakings in which the company has a participating interest 2,048,800 2,048,800
Other debtors 2,060,000 1,946,500
4,108,800 3,995,300
10 Creditors: amounts falling due within one year 2025 2024
£ £
Other taxes and social security 139,508 106,259
Corporation tax 123,744 184,301
Other creditors 197,111 314,090
460,363 604,650
11 Creditors: amounts falling due after one year 2025 2024
£ £
Bank loans 3,664,691 3,961,150
Obligations under finance lease and hire purchase contracts 79,695 108,675
3,744,386 4,069,825
12 Loans 2025 2024
£ £
Loans repayable after five years:
Loans 3,664,691 3,961,150
Analysis of maturity of debt:
After five years 3,664,691 3,961,150
The bank loans are secured by way of debenture and legal charges over the property owned by
the company. These were registered as Charges at Companies House on 13/11/2023.
13 Obligations under finance leases and hire purchase 2025 2024
contracts £ £
Amounts payable:
Within two to five years 79,695 108,675
14 Share capital Nominal 2025 2025 2024
value Number £ £
Allotted, called up and fully paid:
Ordinary shares £1 each 1,000 1,000 1,000
15 Other reserves 2025 2024
Revaluation reserve £ £
Gain on revaluation of land and buildings 2,955,000 2,955,000
At 31 October 2,955,000 2,955,000
16 Profit and loss account 2025 2024
£ £
At 1 November 5,022,036 4,503,143
Profit for the financial year 502,258 518,893
At 31 October 5,524,294 5,022,036
17 Related party transactions
The company transacted with other companies that the the directors hold shares in. See notes 11 and 12 (group, other debtors and other creditors).
18 Controlling party
The directors are the controlling party because they are also the shareholders.
19 Presentation currency
The financial statements are presented in Sterling.
20 Legal form of entity and country of incorporation
National Care Consortium Limited is a private company limited by shares and incorporated in England.
21 Principal place of business
The address of the company's principal place of business and registered office is:
Younas House
1 Pelham Court
Pelham Road
Nottingham
NG5 1AP
National Care Consortium Limited 10765210 false 2024-11-01 2025-10-31 2025-10-31 VT Final Accounts February 2026 10765210 2023-11-01 2024-10-31 10765210 core:OtherReservesSubtotal core:LandBuildings 2023-11-01 2024-10-31 10765210 core:LandBuildings 2023-11-01 2024-10-31 10765210 core:ShareCapital 2023-11-01 2024-10-31 10765210 core:SharePremium 2023-11-01 2024-10-31 10765210 core:OtherReservesSubtotal 2023-11-01 2024-10-31 10765210 core:RetainedEarningsAccumulatedLosses 2023-11-01 2024-10-31 10765210 countries:UnitedKingdom 2023-11-01 2024-10-31 10765210 core:OwnedAssets 2023-11-01 2024-10-31 10765210 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 10765210 core:RevaluationReserve core:LandBuildings 2023-11-01 2024-10-31 10765210 core:WithinOneYear 2024-10-31 10765210 core:AfterOneYear 2024-10-31 10765210 core:ShareCapital 2024-10-31 10765210 core:OtherReservesSubtotal 2024-10-31 10765210 core:RetainedEarningsAccumulatedLosses 2024-10-31 10765210 core:LeasedAssetsHeldAsLessee core:VehiclesPlantMachinery 2024-10-31 10765210 1 2024-10-31 10765210 core:MoreThanFiveYears 2024-10-31 10765210 core:BetweenTwoFiveYears 2024-10-31 10765210 core:RevaluationReserve 2024-10-31 10765210 2023-10-31 10765210 core:ShareCapital 2023-10-31 10765210 core:SharePremium 2023-10-31 10765210 core:OtherReservesSubtotal 2023-10-31 10765210 core:RetainedEarningsAccumulatedLosses 2023-10-31 10765210 2024-11-01 2025-10-31 10765210 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 10765210 bus:Audited 2024-11-01 2025-10-31 10765210 bus:Director1 2024-11-01 2025-10-31 10765210 bus:Director2 2024-11-01 2025-10-31 10765210 bus:Director3 2024-11-01 2025-10-31 10765210 bus:Director4 2024-11-01 2025-10-31 10765210 bus:Director5 2024-11-01 2025-10-31 10765210 core:RetainedEarningsAccumulatedLosses 2024-11-01 2025-10-31 10765210 core:OtherReservesSubtotal core:LandBuildings 2024-11-01 2025-10-31 10765210 core:LandBuildings 2024-11-01 2025-10-31 10765210 core:ShareCapital 2024-11-01 2025-10-31 10765210 core:SharePremium 2024-11-01 2025-10-31 10765210 core:OtherReservesSubtotal 2024-11-01 2025-10-31 10765210 1 2024-11-01 2025-10-31 10765210 2 2024-11-01 2025-10-31 10765210 countries:UnitedKingdom 2024-11-01 2025-10-31 10765210 core:OwnedAssets 2024-11-01 2025-10-31 10765210 core:VehiclesPlantMachinery 2024-11-01 2025-10-31 10765210 core:FurnitureFittingsToolsEquipment 2024-11-01 2025-10-31 10765210 1 2024-11-01 2025-10-31 10765210 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 10765210 core:RevaluationReserve core:LandBuildings 2024-11-01 2025-10-31 10765210 countries:England 2024-11-01 2025-10-31 10765210 bus:FRS102 2024-11-01 2025-10-31 10765210 bus:FullAccounts 2024-11-01 2025-10-31 10765210 2025-10-31 10765210 core:WithinOneYear 2025-10-31 10765210 core:AfterOneYear 2025-10-31 10765210 core:ShareCapital 2025-10-31 10765210 core:OtherReservesSubtotal 2025-10-31 10765210 core:RetainedEarningsAccumulatedLosses 2025-10-31 10765210 core:SharePremium 2025-10-31 10765210 core:LandBuildings 2025-10-31 10765210 core:VehiclesPlantMachinery 2025-10-31 10765210 core:FurnitureFittingsToolsEquipment 2025-10-31 10765210 core:LeasedAssetsHeldAsLessee core:VehiclesPlantMachinery 2025-10-31 10765210 1 2025-10-31 10765210 core:MoreThanFiveYears 2025-10-31 10765210 core:BetweenTwoFiveYears 2025-10-31 10765210 bus:OrdinaryShareClass1 2025-10-31 10765210 core:RevaluationReserve 2025-10-31 10765210 2024-10-31 10765210 core:SharePremium 2024-10-31 10765210 core:LandBuildings 2024-10-31 10765210 core:VehiclesPlantMachinery 2024-10-31 10765210 core:FurnitureFittingsToolsEquipment 2024-10-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:pure xbrli:shares